|Bid||26.06 x 1100|
|Ask||26.33 x 1400|
|Day's Range||26.07 - 26.11|
|52 Week Range||23.69 - 27.57|
|Beta (5Y Monthly)||0.93|
|PE Ratio (TTM)||53.39|
|Forward Dividend & Yield||2.16 (8.27%)|
|Ex-Dividend Date||Sep. 30, 2021|
|1y Target Est||N/A|
Xoma (XOMA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
EMERYVILLE, Calif., Sept. 22, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA)’s Chief Executive Officer, Jim Neal, will present at the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference on Tuesday, September 28, 2021, at 10:20 AM PT. About XOMA CorporationXOMA is a biotechnology royalty aggregator playing a unique role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeuti
A look at the shareholders of XOMA Corporation ( NASDAQ:XOMA ) can tell us which group is most powerful. Generally...